These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2966605)

  • 1. In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences.
    Wong DF; Broussolle EP; Wand G; Villemagne V; Dannals RF; Links JM; Zacur HA; Harris J; Naidu S; Braestrup C
    Ann N Y Acad Sci; 1988; 515():203-14. PubMed ID: 2966605
    [No Abstract]   [Full Text] [Related]  

  • 2. Imaging dopamine receptors in the human brain by positron tomography.
    Wagner HN; Burns HD; Dannals RF; Wong DF; Langstrom B; Duelfer T; Frost JJ; Ravert HT; Links JM; Rosenbloom SB; Lukas SE; Kramer AV; Kuhar MJ
    Science; 1983 Sep; 221(4617):1264-6. PubMed ID: 6604315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron tomographic quantitation of neuroreceptors in human brain in vivo--with special reference to the D2 dopamine receptors in caudate nucleus.
    Gjedde A; Wong DF
    Neurosurg Rev; 1987; 10(1):9-18. PubMed ID: 2959876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands.
    Wong DF; Gjedde A; Wagner HN
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):137-46. PubMed ID: 2937794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorbed fractions for dose calculations of neuroreceptor PET studies.
    Bice AN; Links JM; Wong DF; Wagner HN
    Eur J Nucl Med; 1985; 11(4):127-31. PubMed ID: 3876935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated D2 in schizophrenia: role of endogenous dopamine and cerebellum. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Seeman P
    Neuropsychopharmacology; 1992 Aug; 7(1):55-7; discussion 73-5. PubMed ID: 1388022
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain.
    Wong DF; Wagner HN; Dannals RF; Links JM; Frost JJ; Ravert HT; Wilson AA; Rosenbaum AE; Gjedde A; Douglass KH
    Science; 1984 Dec; 226(4681):1393-6. PubMed ID: 6334363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of Neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity.
    Wong DF; Gjedde A; Wagner HN; Dannals RF; Douglass KH; Links JM; Kuhar MJ
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):147-53. PubMed ID: 2937795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.
    Bahn MM; Huang SC; Hawkins RA; Satyamurthy N; Hoffman JM; Barrio JR; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):840-9. PubMed ID: 2531147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride.
    Antonini A; Leenders KL
    Ann N Y Acad Sci; 1993 Sep; 695():81-5. PubMed ID: 8239318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET studies of dopamine receptor distribution using [18F]fluoroethylspiperone: findings in disorders related to the dopaminergic system.
    Wienhard K; Coenen HH; Pawlik G; Rudolf J; Laufer P; Jovkar S; Stöcklin G; Heiss WD
    J Neural Transm Gen Sect; 1990; 81(3):195-213. PubMed ID: 2144427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of menstrual cycle phase on dopamine D2 receptor availability in female cynomolgus monkeys.
    Czoty PW; Riddick NV; Gage HD; Sandridge M; Nader SH; Garg S; Bounds M; Garg PK; Nader MA
    Neuropsychopharmacology; 2009 Feb; 34(3):548-54. PubMed ID: 18256593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of central [76Br]bromolisuride binding to dopamine D2 receptors studied by PET.
    Delforge J; Loc'h C; Hantraye P; Stulzaft O; Khalili-Varasteh M; Mazière M; Syrota A; Mazière B
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):914-25. PubMed ID: 1834685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates.
    Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET.
    Arnett CD; Wolf AP; Shiue CY; Fowler JS; MacGregor RR; Christman DR; Smith MR
    J Nucl Med; 1986 Dec; 27(12):1878-82. PubMed ID: 3491193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography studies of brain receptors.
    Mazière B; Mazière M
    Fundam Clin Pharmacol; 1991; 5(1):61-91. PubMed ID: 1676695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
    Hagelberg N; Kajander JK; Någren K; Hinkka S; Hietala J; Scheinin H
    Synapse; 2002 Jul; 45(1):25-30. PubMed ID: 12112410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals.
    Volkow ND; Gur RC; Wang GJ; Fowler JS; Moberg PJ; Ding YS; Hitzemann R; Smith G; Logan J
    Am J Psychiatry; 1998 Mar; 155(3):344-9. PubMed ID: 9501743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonist.
    Singhaniyom W; Tsai YF; Brücke T; McLellan CA; Cohen RM; Kung HF; Chiueh CC
    Brain Res; 1988 Jun; 453(1-2):393-6. PubMed ID: 2969766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.
    Brody AL; Mandelkern MA; Olmstead RE; Scheibal D; Hahn E; Shiraga S; Zamora-Paja E; Farahi J; Saxena S; London ED; McCracken JT
    Arch Gen Psychiatry; 2006 Jul; 63(7):808-16. PubMed ID: 16818870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.